5% of Covaxin royalty to ICMR raises questions

5% of Covaxin royalty to ICMR raises questions Bharat Biotech will pay a royalty of 5% on the net sales of Covaxin, its Covid-19 vaccine, to Indian Council of Medical Research (ICMR).This has prompted public health and intellectual property experts to voice concerns. https://ift.tt/eA8V8J